Table 4.
Inappropriate Use of Acid-Suppressive Drugs (Phase 2 Interventions versus Phase 1 Historical Controls)
| Group | No. of Patients Using ASMs | No. of Patients Using Inappropriate ASMs (%) | PValue |
|---|---|---|---|
| Historical controls Phase 1 (2005) | 170 | 101 (59%) | — |
| Intervention A Phase 2 (2006, IBC alone) | 152 | 56 (37%) | <0.001 |
| Intervention B Phase 2 (2006, IBC + BML) | 77 | 25 (32%) | <0.001 |
| Intervention C Phase 2 (2006, IBC + BML + CPI) | 73 | 1 (19%) | <0.001 |
ASM = acid-suppressive medication (either a histamine H2 antagonist or a proton pump inhibitor); IBC = intern boot camp; BML = beginning-of-month lecture; CPI = clinical pharmacist intervention; No. = total number of patients admitted on service.